Latest papers

3rd Global Vaccine Congress.

African trypanosomiasis and antibodies: implications for vaccination, therapy and diagnosis.

Toxoplasma vaccines: appropriate end points and sample size in future human clinical trials.

Immunolocalization and challenge studies using a recombinant Vibrio cholerae ghost expressing Trypanosoma brucei Ca(2+) ATPase (TBCA2) antigen.

Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection

Kinetoplastid papain-like cysteine peptidases.

Evaluation of protective immunity of 28KD-GST as a vaccine against experimental Schistosoma mansoni.

Perspectives of vaccination in Chagas disease revisited.

High hydrostatic pressure for development of vaccines.

Protective immunity against Trypanosoma cruzi.

Toxoplasma gondii: 25 years and 25 major advances for the field.

Swimming against the current: genetic vaccination against Trypanosoma cruzi infection in mice.

Comparison of Babesia rossi and Babesia canis isolates with emphasis on effects of vaccination with soluble parasite antigens: a review.

The IL-6-deficient mouse exhibits impaired lymphocytic responses to a vaccine combining live Leishmania major and CpG oligodeoxynucleotides.

Vaccination route that induces transforming growth factor beta production fails to elicit protective immunity against Leishmania donovani infection.

Veterinary vaccines against Toxoplasma gondii.

The use of genomics in microbial vaccine development

Advances in understanding immunity to Toxoplasma gondii.

Vaccines against Toxoplasma gondii: challenges and opportunities

Vaccination concepts against Toxoplasma gondii.